Bloomberg reported that Pfizer Inc. is planning to acquire Agila Specialties Private Limited for a possible price of $2 billion. Bloomberg reported citing unnamed sources that Pfizer is conducting due diligence on Agila and a formal deal could be reached in the first quarter of 2013. Reuters said that a Pfizer spokeswoman said that the company does not comment on market rumors.
Market Closed -
Other stock markets
|
Pre-market 04:54:13 pm | |||
29.5 USD | +1.37% |
|
29.37 | -0.44% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.47% | 17TCr | |
+61.53% | 85TCr | |
+33.35% | 63TCr | |
-3.66% | 36TCr | |
+15.06% | 32TCr | |
+9.18% | 30TCr | |
+12.39% | 23TCr | |
+16.22% | 23TCr | |
+15.67% | 18TCr | |
+2.37% | 13TCr |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Pfizer Reportedly Plans To Acquire Agila Specialties